Related Experiment Video
Updated: Nov 18, 2025
07:51
Administration of Δ9-Tetrahydrocannabinol (THC) in Adolescent and Adult Mice
Published on: August 1, 2025
522
Cannabis for Restless Legs Syndrome
Imad Ghorayeb1,2,3
1Département de Neurophysiologie Clinique, Pôle Neurosciences Cliniques, Bordeaux, France. imad.ghorayeb@u-bordeaux.fr.
Advances in Experimental Medicine and Biology
|February 4, 2021
Summary
Restless Legs Syndrome (RLS) is a neurological disorder impacting millions. Emerging evidence suggests cannabis may offer relief for RLS patients, particularly those unresponsive to traditional treatments.
Area of Science:
- Neurology
- Pharmacology
Background:
- Restless Legs Syndrome (RLS) is a chronic sensorimotor disorder affecting 3% of the population, significantly impacting quality of life and sleep.
- Current treatments like dopamine agonists have limitations, including refractory cases and side effects such as augmentation and impulse control disorder.
Purpose of the Study:
- To review current knowledge of RLS pathophysiology.
- To explore the potential of cannabis as a treatment alternative for refractory RLS.
Main Methods:
- Literature review of RLS.
- Review of studies on cannabis and pain relief.
- Analysis of anecdotal reports on cannabis for RLS.
Main Results:
- RLS pathophysiology is not fully understood.
- Cannabis has demonstrated antinociceptive effects in other neurological conditions.
- Anecdotal reports suggest cannabis may induce remission of RLS symptoms.
Conclusions:
- Cannabis warrants investigation as a potential treatment for RLS, especially in treatment-refractory cases.
- Further clinical trials are needed to validate the efficacy and safety of cannabis for RLS.
Related Concept Videos
01:27Restless Leg Syndrome and Night Terrors
328
Restless Leg Syndrome (RLS), also known as Willis-Ekbom disease, is a neurological disorder characterized by an uncontrollable urge to move the legs due to uncomfortable sensations. These sensations typically occur during periods of rest or inactivity, particularly when lying down or sitting, and can severely disrupt sleep.
The exact cause of RLS is not fully understood, but it is believed to involve dopamine, a neurotransmitter that helps regulate muscle movement. Imbalances in dopamine levels...
The exact cause of RLS is not fully understood, but it is believed to involve dopamine, a neurotransmitter that helps regulate muscle movement. Imbalances in dopamine levels...
328
01:15REM Sleep Behavior Disorder
857
REM Sleep Behavior Disorder (RBD) is a sleep disorder characterized by the absence of muscle paralysis that normally occurs during the REM phase of sleep. This absence allows individuals to physically act out their dreams, which are often vivid and disturbing. Common behaviors exhibited during episodes include kicking, punching, and yelling. These actions can be dangerous, potentially leading to injuries for the person with RBD or their bed partner.
RBD is significantly associated with...
RBD is significantly associated with...
857
01:21Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
509
Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...
Two synthetic agonists of THC,...
509
01:24CNS Stimulants: Cocaine, Amphetamines and Cannabinoids
517
CNS stimulants, such as cocaine, amphetamines, and cannabinoids, have varying structures and mechanisms of action that lead to different therapeutic effects and side effects. Cocaine, with its molecular formula C17H21NO4, is a tropane alkaloid and a tertiary amino compound. It has two chemical forms: the hydrochloride salt and the "freebase." The former is in powder form, while the latter involves removing the hydrochloride salt to create a form that can be smoked. Cocaine exerts its...
517
01:21Drugs for Treatment of Constipation-Predominant IBS
477
Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
477
01:17Drugs for Treatment of Diarrhea-Predominant IBS
431
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
431